Aarti K Bhatia (Aarti Bhatia)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Epidermal Growth Factor Receptor

Monoclonal Antibody

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Aarti K Bhatia, Barbara Burtness
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update. Drugs 83 (3) (2023)
Aarti K Bhatia, Barbara Burtness
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update. Drugs 83 (3) (2023)
Aarti K Bhatia, Barbara Burtness
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update. Drugs 83 (3) (2023)
Aarti K Bhatia, Barbara Burtness
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update. Drugs (2023)
Aarti K Bhatia, Ju-Whei Lee, Harlan A Pinto, Charlotte D Jacobs, Paul J Limburg, Philip Rubin, Robert M Arusell, Eamonn P Dunphy, Janardan D Khandekar, Seth A Reiner, Luis Baez-Diaz, Paul Celano, Shuli Li, Yi Li, Barbara A Burtness, George L Adams, Kishan J Pandya
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). Cancer 123 (23) (2017)
Shayan Cheraghlou, Phoebe K Yu, Michael D Otremba, Henry S Park, Aarti K Bhatia, Cheryl K Zogg, Saral Mehra, Wendell G Yarbrough, Benjamin L Judson
Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base. Cancer 124 (4) (2017)